HENWOOD GERALDINE (President and CEO) reported 2 transactions at BAUDAX BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/9/2020ACC: 0001192482-20-000810
DirectorOfficer· President and CEO
Since Nov 2019
-83.02K
Net shares
Net seller
$94.6K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
83.02K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−11.73K
Price / share
$1.14
Trade value
$13.37K
% of position
3.2%
12/5/2020
367.89K→356.15K
Common Stock
Direct
Shares
−71.28K
Price / share
$1.14
Trade value
$81.26K
% of position
20.0%
12/5/2020
356.15K→284.87K
Total
Net shares
−83.02K
Net value
-$94.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2020 | F · Tax Withholding | −11.73K | $1.14 | $13.37K | 3.2% | 367.89K | 356.15K |
| Common Stock Direct | 12/5/2020 | F · Tax Withholding | −71.28K | $1.14 | $81.26K | 20.0% | 356.15K | 284.87K |
| Total | −83.02K | -$94.64K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20K
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported